We are monitoring the impact of COVID-19 & Recession alarm on DNA Testing Market Get in touch with us for detailed analysis Know More

Know More

Share on

Global DNA Testing Market Size, Share, Trends, COVID-19 Impact & Growth Forecast Report – Segmented By Type, Technology, Application & Region – Industry Analysis from 2022 to 2027

Published: January, 2022
ID: 12462
Pages: 190

Global DNA Testing Market Size (2022 to 2027)

Between 2022 to 2027, the global DNA testing market is predicted to expand at a CAGR of 12.4% and worth USD 30.53 billion by 2027 from USD 17.02 billion in 2022.

A type of medical test that detects alterations in chromosomes, genes, or proteins is known as DNA testing. The findings of a DNA test can confirm a suspected genetic issue and assist in managing a person's risk of getting or passing on a genetic disorder. Measurement of the results of genetic changes, such as RNA analysis as a gene expression output or biochemical analysis to quantify specific protein output, can also be part of genetic testing.

Impact of COVID-19 on the global DNA testing market:

During the COVID-19 epidemic, the global DNA testing market has been on positive growth. To combat the spread of the SARS-CoV2 virus, most DNA testing facilities have utilized virtualization and home testing kits/home sample collection. On the other hand, obtaining DNA testing blood draws was difficult, resulting in a severely impacted genetic testing observed during the virtual care period. As a result, during the current crisis, COVID-19 is likely to, directly and indirectly, affect the global DNA testing market.

MARKET DRIVERS:

As technological improvements lead to the commercialization of next-generation testing and diagnostic solutions based on genetic analysis, the global market for DNA testing is expected to rise.

The expansion of the DNA test kits market is also further influenced by the number of direct-to-consumer testing companies that offer DNA tests for preventative care, health & fitness, and ancestry. The market's expansion is also expected to be aided by government-funded research and development projects. In addition, the introduction of novel technologies to advance genome profiling. Increased incidences of infectious diseases and chronic oncology, both of which rely exclusively on DNA prototyping for therapy, are likely to accelerate the expansion of the global DNA testing market. The presence of well-known market companies involved in genetic testing and a favorable regulatory environment contributes to the global DNA testing market.

The global DNA testing market is also estimated to grow due to the rising incidence of blood cancer, genetic abnormalities, cardiovascular diseases, technical improvements, and novel tests. More cancer patients will be successfully treated due to advancements in cancer research, propelling the market growth. In addition, developing efficient and highly sensitive DNA sequencing technologies for prenatal genetic testing has opened up new possibilities for first screening tests in future pregnancies. Small amounts of fetal DNA that circulate naturally in the mother's blood during pregnancy can be detected using these procedures. Furthermore, next-generation sequencing (NGS), a rapidly emerging technique that permits the sequencing of a complete genome or a section of a genome and the rapid extraction of genetic information from biological materials, will soon hasten the acceptance of DNA tests.

MARKET RESTRAINTS:

The expansion of the DNA testing market is predicted to be hampered by the high testing prices and a scarcity of competent practitioners. Furthermore, during the forecast period, the global DNA testing market is also expected to be inhibited by concerns about the uniformity of testing-based diagnoses and stringent regulatory requirements for product approvals.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Type, Technology, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global DNA testing market has been segmented and sub-segmented based on type, application, technology, and region.

DNA Testing Market – By Type:

  • Predictive & Presymptomatic Testing
  • Carrier Testing
  • Prenatal & Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

The prenatal & newborn testing segment was the most profitable based on type in 2021, which is likely to continue during the forecast period. This is due to a rise in public awareness about healthcare and an increase in individuals dying from hereditary disorders worldwide.

DNA Testing Market – By Application:

  • Cancer diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Others

Based on the application, the cancer diagnosis segment is expected to dominate the global DNA testing market. During the forecast period, DNA (genetic) testing aids in determining a person's chance of acquiring various cancers during their lifespan. In addition, genetic tests are available to check for inherited variations and mutations in the DNA sequence that could cause cells to expand too quickly and cause tumors or cancer.

DNA Testing Market – By Technology:

  • Cytogenetic testing/chromosome analysis
  • Biochemical testing
  • Molecular testing
    • DNA Sequencing
    • Others

The molecular testing segment dominated the global DNA testing market in 2021. The fact that molecular testing is the most widely utilized technology for DNA testing contributes to the segment's growth. DNA tests such as carrier testing, diagnostic testing, predictive and presymptomatic testing, and others, for example, employ the technology. Furthermore, molecular testing is recommended because it may be utilized to assess DNA gains or losses that are not identifiable by standard chromosome examination.

DNA Testing Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Due to individuals becoming more aware of modern healthcare treatments, the North American DNA testing market was leading the global market with the largest share in 2021. Its substantial proportion is due to the presence of key players, developed healthcare infrastructure, and the availability of branded pharmaceuticals, to name a few aspects. In addition, the rising number of people diagnosed with blood cancer is driving the expansion of the DNA testing market in this region. In the next few years, companies' favorable government legislation and proactive initiatives to expand the reach of screening among patients are projected to help the expansion of the U.S. DNA Testing Industry.

Due to rising healthcare expenditures, significant population rates, rising prevalence of cardiac diseases, rising awareness about early diagnosis, developing healthcare infrastructure, and availability of effective treatment in emerging countries such as China and India, the Asia Pacific is expected to be the fastest-growing regional market over the forecast period. In addition, Asia Pacific is at the forefront of blood cancer treatment innovation, producing and delivering life-extending and improving medicines. These are the primary elements that are propelling the DNA testing market forward. Direct-to-consumer genetic testing kits are quickly increasing in nations such as the United States, China, and Japan. The market for DTC-GT (Direct-to-Consumer Genetic Testing) kits is expected to grow significantly throughout the period due to solid technological adoption, awareness initiatives, and lower pricing. Furthermore, underdeveloped countries such as India and other developing countries are likely to present a profitable potential for firms seeking to gain a base in the DNA testing industry.

Due to the increased availability of direct-to-consumer testing services and a growing focus on distribution, Europe is also a lucrative region.

KEY MARKET PARTICIPANTS:

Abbott Laboratories, Bio-Rad Laboratories, Inc., CSL Ltd, Danaher Corporation (Cepheid), Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, Inc. (Myriad RBM, Inc.), and Thermo Fisher Scientific, Inc. are some of the noteworthy companies in the global DNA testing market and profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

  • In November 2020, the FDA expanded its approval of a cancer blood test known as liquid biopsy, which detects genetic alterations in tumor DNA in the blood and can help match patients to prospective treatments.
  • Illumina Inc. signed a definitive deal to buy GRAIL in September 2020 to add a transformational multi-cancer screening test (based on next-generation sequencing (NGS)) to its portfolio.
  • The FDA authorized Guardant360 CDx from Guardant Health and FoundationOne Liquid CDx from Foundation Medicine in August 2020 as a companion diagnostic test and for general tumor profiling.
  1. Introduction                                 
    1. Market Definition                    
    2. Scope of the report                 
    3. Study Assumptions                 
    4. Base Currency, Base Year and Forecast Periods                           
  2. Research Methodology                                           
    1. Analysis Design                         
    2. Research Phases                      
      1. Secondary Research           
      2. Primary Research 
      3. Data Modelling     
      4. Expert Validation  
    3. Study Timeline                          
  3. Report Overview                                        
    1. Executive Summary                
    2. Key Inferences                       
  4. Market Dynamics                                       
    1. Impact Analysis                        
      1. Drivers      
      2. Restraints 
      3. Opportunities        
    2. Regulatory Environment                       
    3. Technology Timeline & Recent Trends                            
  5. Competitor Benchmarking Analysis                                    
    1. Key Player Benchmarking                     
      1. Market share analysis         
      2. Products/Service 
      3. Regional Presence
    2. Mergers & Acquisition Landscape                      
    3. Joint Ventures & Collaborations                        
  6. Market Segmentation                                              
    1. Global DNA Testing Market, By Type
      1. Predictive & Presymptomatic Testing
      2. Carrier Testing
      3. Prenatal & Newborn Testing
      4. Diagnostic Testing
      5. Pharmacogenomic Testing
      6. Others
      7. Market Size Estimations & Forecasts (2022 - 2027)   
      8. Y-o-Y Growth Rate Analysis              
      9. Market Attractiveness Index           
    2. Global DNA Testing Market, By Application
      1. Cancer diagnosis
      2. Genetic Disease Diagnosis
      3. Cardiovascular Disease Diagnosis
      4. Others
      5. Market Size Estimations & Forecasts (2022 - 2027)   
      6. Y-o-Y Growth Rate Analysis              
      7. Market Attractiveness Index         
    3. Global DNA Testing Market, By Technology
      1. Cytogenetic testing/chromosome analysis
      2. Biochemical testing
      3. Molecular testing
        1. DNA Sequencing
        2. Others
      4. Market Size Estimations & Forecasts (2022 - 2027)  
      5. Y-o-Y Growth Rate Analysis             
      6. Market Attractiveness Index        
  7. Geographical Landscape                                         
    1. Global DNA Testing Market, By Region                 
    2. North America - Market Analysis (2022 - 2027)                            
      1. By Country              
        1. USA
        2. Canada
    3. Europe                         
      1. By Country              
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                  
      1. By Country              
        1. China
        2. India
        3. Japan
        4. South Korea
        5. South East Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
    5. Latin America                            
      1. By Country              
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
    6. Middle East and Africa                           
      1. By Country              
        1. Middle East
        2. Africa
  8. Key Player Analysis                                    
    1. Abbott Laboratories
      1. Business Description           
      2. Products/Service 
      3. Financials 
      4. SWOT Analysis      
      5. Recent Developments       
      6. Analyst Overview 
    2. Bio-Rad Laboratories, Inc.
    3. CSL Ltd
    4. Danaher Corporation (Cepheid)
    5. Eurofins Scientific
    6. F. Hoffmann-La Roche Ltd.
    7.  Illumina, Inc.
    8. Myriad Genetics, Inc. (Myriad RBM, Inc.)
    9. Thermo Fisher Scientific, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix
    1. List of Tables
    2. List of Figures
  1. Global DNA Testing Market, By Region, From 2027 to 2027 (USD Billion)
  2. Global DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  3. Global Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  4. Global Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  5. Global Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  6. Global Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  7. Global Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  8. Global Others Market, By Region, From 2027 to 2027 (USD Billion)
  9. Global DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  10. Global Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  11. Global Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  12. Global Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  13. Global Others Market, By Region, From 2027 to 2027 (USD Billion)
  14. Global DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  15. Global Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  16. Global Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  17. Global Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  18. Global DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  19. Global DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  20. Global Others Market, By Region, From 2027 to 2027 (USD Billion)
  21. North America DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  22. North America Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  23. North America Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  24. North America Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  25. North America Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  26. North America Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  27. North America Others Market, By Region, From 2027 to 2027 (USD Billion)
  28. North America DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  29. North America Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  30. North America Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  31. North America Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  32. North America Others Market, By Region, From 2027 to 2027 (USD Billion)
  33. United States DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  34. United States DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  35. Canada DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  36. Canada DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  37. North America DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  38. North America Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  39. North America Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  40. North America Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  41. United States DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  42. Canada DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  43. North America DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  44. North America DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  45. North America Others Market, By Region, From 2027 to 2027 (USD Billion)
  46. United States DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  47. Canada DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  48. Europe DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  49. Europe Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  50. Europe Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  51. Europe Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  52. Europe Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  53. Europe Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  54. Europe Others Market, By Region, From 2027 to 2027 (USD Billion)
  55. Europe DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  56. Europe Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  57. Europe Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  58. Europe Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  59. Europe Others Market, By Region, From 2027 to 2027 (USD Billion)
  60. U.K. DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  61. U.K. DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  62. Germany DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  63. Germany DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  64. France DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  65. France DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  66. Italy DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  67. Italy DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  68. Spain DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  69. Spain DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  70. Europe DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  71. Europe Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  72. Europe Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  73. Europe Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  74. U.K. DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  75. Germany DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  76. France DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  77. Italy DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  78. Spain DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  79. Europe DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  80. Europe DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  81. Europe Others Market, By Region, From 2027 to 2027 (USD Billion)
  82. U.K. DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  83. Germany DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  84. France DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  85. Italy DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  86. Spain DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  87. Asia Pacific DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  88. Asia Pacific Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  89. Asia Pacific Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  90. Asia Pacific Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  91. Asia Pacific Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  92. Asia Pacific Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  93. Asia Pacific Others Market, By Region, From 2027 to 2027 (USD Billion)
  94. Asia Pacific DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  95. Asia Pacific Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  96. Asia Pacific Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  97. Asia Pacific Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  98. Asia Pacific Others Market, By Region, From 2027 to 2027 (USD Billion)
  99. Japan DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  100. Japan DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  101. China DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  102. China DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  103. India DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  104. India DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  105. Australia DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  106. Australia DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  107. South Korea DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  108. South Korea DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  109. Asia Pacific DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  110. Asia Pacific Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  111. Asia Pacific Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  112. Asia Pacific Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  113. Japan DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  114. China DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  115. India DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  116. Australia DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  117. Asia Pacific DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  118. Asia Pacific DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  119. Asia Pacific Others Market, By Region, From 2027 to 2027 (USD Billion)
  120. Japan DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  121. China DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  122. India DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  123. Australia DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  124. Latin America DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  125. Latin America Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  126. Latin America Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  127. Latin America Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  128. Latin America Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  129. Latin America Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  130. Latin America Others Market, By Region, From 2027 to 2027 (USD Billion)
  131. Latin America DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  132. Latin America Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  133. Latin America Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  134. Latin America Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  135. Latin America Others Market, By Region, From 2027 to 2027 (USD Billion)
  136. Brazil DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  137. Brazil DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  138. Argentina DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  139. Argentina DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  140. Mexico DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  141. Mexico DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  142. Rest of Latin America DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  143. Rest of Latin America DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  144. Latin America DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  145. Latin America Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  146. Latin America Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  147. Latin America Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  148. Brazil DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  149. Argentina DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  150. Mexico DNA Testing Market, By  By Technology, From 2027 to 2027 (USD Billion)
  151. Latin America DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  152. Latin America DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  153. Latin America Others Market, By Region, From 2027 to 2027 (USD Billion)
  154. Brazil DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  155. Argentina DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  156. Mexico DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  157. Middle East and Africa DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  158. Middle East and Africa Predictive & Presymptomatic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  159. Middle East and Africa Carrier Testing Market, By Region, From 2027 to 2027 (USD Billion)
  160. Middle East and Africa Prenatal & Newborn Testing Market, By Region, From 2027 to 2027 (USD Billion)
  161. Middle East and Africa Diagnostic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  162. Middle East and Africa Pharmacogenomic Testing Market, By Region, From 2027 to 2027 (USD Billion)
  163. Middle East and Africa Others Market, By Region, From 2027 to 2027 (USD Billion)
  164. Middle East and Africa DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  165. Middle East and Africa Cancer diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  166. Middle East and Africa Genetic Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  167. Middle East and Africa Cardiovascular Disease Diagnosis Market, By Region, From 2027 to 2027 (USD Billion)
  168. Middle East and Africa Others Market, By Region, From 2027 to 2027 (USD Billion)
  169. Middle East DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  170. Middle East DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  171. Africa DNA Testing Market, By Type, From 2027 to 2027 (USD Billion)
  172. Africa DNA Testing Market, By Application, From 2027 to 2027 (USD Billion)
  173. Middle East and Africa DNA Testing Market, By Technology, From 2027 to 2027 (USD Billion)
  174. Middle East and Africa Cytogenetic testing/chromosome analysis Market, By Region, From 2027 to 2027 (USD Billion)
  175. Middle East and Africa Biochemical testing Market, By Region, From 2027 to 2027 (USD Billion)
  176. Middle East and Africa Molecular testing Market, By Region, From 2027 to 2027 (USD Billion)
  177. Middle East DNA Testing Market, By Technology, From 2027 to 2027 (USD Billion)
  178. Africa DNA Testing Market, By Technology, From 2027 to 2027 (USD Billion)
  179. Middle East and Africa DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  180. Middle East and Africa DNA Sequencing Market, By Region, From 2027 to 2027 (USD Billion)
  181. Middle East and Africa Others Market, By Region, From 2027 to 2027 (USD Billion)
  182. Middle East DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)
  183. Africa DNA Testing Market, By Molecular testing, From 2027 to 2027 (USD Billion)

Please wait. . . . Your request is being processed

FAQ's

How big is the global DNA testing market?

The global DNA testing market size is estimated to grow to USD 30.53 billion by 2027 from USD 17.02 billion in 2022.

Which segment by type is expected to lead the DNA testing market in the coming years?

The prenatal & newborn testing segment led the DNA testing market in 2021 and this domination is expected to be continued throughout the forecast period.

Which segment by application is predicted to dominate in the DNA testing market in the coming years?

By application, the cancer diagnosis segment is predicted to be leading from 2022 to 2027 in the global DNA testing market.

Which are the companies playing a key role in the DNA testing market?

Abbott Laboratories, Bio-Rad Laboratories, Inc., CSL Ltd, Danaher Corporation (Cepheid), Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, Inc. (Myriad RBM, Inc.), and Thermo Fisher Scientific, Inc. are a few of the noteworthy companies operating in the global DNA testing market.

Related Reports

PURCHASE OPTIONS

pdf
$

4255


pdf excel
$

5520


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample